Personalized medicine for non-small cell lung cancer patients treated with epidermal growth factor receptor tyrosine kinase inhibitor, erlotinib

被引：0
|
作者：
Hamada, Akinobu
Sasaki, Ji-ichiro
Saeki, Sho
Iwamoto, Norihiro
Inaba, Megumi
Ushijima, Sunao
Urata, Maki
Kishi, Hiroto
Fujii, Shinji
Semba, Hiroshi
Kai, Yuki
Saito, Hideyuki
机构：
来源：
CANCER RESEARCH | 2010年 / 70卷
关键词：
D O I：
10.1158/1538-7445.AM10-3588
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
3588
引用
收藏
页数：3
相关论文
共 50 条
  • [31] Transglutaminase 2 Expression Predicts Progression Free Survival in Non-Small Cell Lung Cancer Patients Treated with Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor
    Jeong, Jae-Heon
    Cho, Byoung Chul
    Shim, Hyo Sup
    Kim, Hye-Ryun
    Lim, Sun-Min
    Kim, Se Kyu
    Chung, Kyung Young
    Islam, S. M. Bakhtiar Ul
    Song, Jae Jin
    Kim, Soo-Youl
    Kim, Joo Hang
    JOURNAL OF KOREAN MEDICAL SCIENCE, 2013, 28 (07) : 1005 - 1014
  • [32] Early radiographic response to epidermal growth factor receptor-tyrosine kinase inhibitor in non-small cell lung cancer patients with epidermal growth factor receptor mutations: A prospective study
    Chang, John W. C.
    Hou, Ming-Mo
    Hsieh, Jia-Juan
    Cheung, Yun-Chung
    Wang, Hung-Ming
    Chen, Jen-Shi
    Wang, Cheng-Hsu
    Chen, Chih-Hung
    Yeh, Kun-Yun
    Ou, Li-Ying
    Hsieh, Chia-Hsun
    Wu, Hong-Dar Isaac
    Chen, Ying-Tsong
    Chang, Il-Chi
    Huang, Shiu-Feng
    BIOMEDICAL JOURNAL, 2015, 38 (03) : 221 - 228
  • [33] Small molecule epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors in non-small cell lung cancer
    Cascone, T
    Morelli, MP
    Ciardiello, F
    ANNALS OF ONCOLOGY, 2006, 17 : 46 - 48
  • [34] Combined therapy with epidermal growth factor receptor tyrosine kinase inhibitors for non-small cell lung cancer
    Iwama, Eiji
    Nakanishi, Yoichi
    Okamoto, Isamu
    EXPERT REVIEW OF ANTICANCER THERAPY, 2018, 18 (03) : 267 - 276
  • [35] Acquired resistance of non-small cell lung cancer to epidermal growth factor receptor tyrosine kinase inhibitors
    Nurwidya, Fariz
    Takahashi, Fumiyuki
    Murakami, Akiko
    Kobayashi, Isao
    Kato, Motoyasu
    Shukuya, Takehito
    Tajima, Ken
    Shimada, Naoko
    Takahashi, Kazuhisa
    RESPIRATORY INVESTIGATION, 2014, 52 (02) : 82 - 91
  • [36] Treatment of Non-small Cell Lung Carcinoma after Failure of Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor
    Lee, Jae Cheol
    Jang, Seung Hun
    Lee, Kye Young
    Kim, Young-Chul
    CANCER RESEARCH AND TREATMENT, 2013, 45 (02): : 79 - 85
  • [37] Targeting mTOR to Overcome Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor Resistance in Non-Small Cell Lung Cancer Cells
    Fei, Shi-Jiang
    Zhang, Xu-Chao
    Dong, Song
    Cheng, Hua
    Zhang, Yi-Fang
    Huang, Ling
    Zhou, Hai-Yu
    Xie, Zhi
    Chen, Zhi-Hong
    Wu, Yi-Long
    PLOS ONE, 2013, 8 (07):
  • [38] Biological markers for non-small cell lung cancer patient selection for epidermal growth factor receptor tyrosine kinase inhibitor therapy
    Bunn, Paul A., Jr.
    Dziadziuszko, Rafal
    Varella-Garcia, Marileila
    Franklin, WilburA.
    Witta, Samir E.
    Kelly, Karen
    Hirsch, Fred R.
    CLINICAL CANCER RESEARCH, 2006, 12 (12) : 3652 - 3656
  • [39] Overcoming resistance to third-generation epidermal growth factor receptor tyrosine kinase inhibitor in non-small cell lung cancer
    Noda-Narita, Shoko
    Kanda, Shintaro
    TRANSLATIONAL CANCER RESEARCH, 2017, 6 : S187 - S190
  • [40] PET probe detecting non-small cell lung cancer susceptible to epidermal growth factor receptor tyrosine kinase inhibitor therapy
    Makino, Akira
    Miyazaki, Anna
    Tomoike, Ayaka
    Kimura, Hiroyuki
    Arimitsu, Kenji
    Hirata, Masahiko
    Ohmomo, Yoshiro
    Nishii, Ryuichi
    Okazawa, Hidehiko
    Kiyono, Yasushi
    Ono, Masahiro
    Saji, Hideo
    BIOORGANIC & MEDICINAL CHEMISTRY, 2018, 26 (08) : 1609 - 1613
12345